CD4 and lymphoma: The control cohort included 56 HIV-positive patients without lymphoma (mean age: 44 ± 9 years) selected to be matched for the CD4+ lymphocyte count with the AIDS-RL: among this population, 9 patients [16%] were not treated by HAART.